Henry Schein (NASDAQ:HSIC) Updates FY25 Earnings Guidance

Henry Schein (NASDAQ:HSIC) issued an update on its FY25 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of $4.80-4.94 for the period, compared to the consensus estimate of $5.00. The company issued revenue guidance of ~$12.93-13.18 billion, compared to the consensus revenue estimate of $13.18 billion. Henry Schein also updated its FY 2025 guidance to 4.800-4.940 EPS.

Henry Schein Stock Up 1.8 %

Shares of NASDAQ HSIC opened at $78.66 on Tuesday. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. Henry Schein has a 12 month low of $63.67 and a 12 month high of $82.63. The firm has a fifty day simple moving average of $74.19 and a two-hundred day simple moving average of $72.38. The firm has a market capitalization of $9.81 billion, a PE ratio of 31.83, a price-to-earnings-growth ratio of 2.13 and a beta of 0.91.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing the consensus estimate of $1.23 by ($0.04). Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The firm had revenue of $3.19 billion for the quarter, compared to analysts’ expectations of $3.25 billion. During the same period in the prior year, the business posted $0.66 EPS. The business’s quarterly revenue was up 5.8% compared to the same quarter last year. Equities analysts expect that Henry Schein will post 4.74 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several analysts have commented on the company. Jefferies Financial Group increased their target price on Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a research note on Thursday, January 23rd. Bank of America raised Henry Schein from an “underperform” rating to a “buy” rating and raised their price objective for the stock from $69.00 to $84.00 in a research note on Monday, January 6th. Barrington Research upped their price target on Henry Schein from $82.00 to $90.00 and gave the stock an “outperform” rating in a research note on Thursday, January 30th. Wells Fargo & Company initiated coverage on Henry Schein in a report on Friday, February 14th. They issued an “equal weight” rating and a $80.00 target price for the company. Finally, StockNews.com upgraded Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Eight research analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $80.09.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.